Earnings Preview: AVDL to Report Financial Results Pre-market on May 07
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7
Express News | Avadel Pharmaceuticals PLC : UBS Cuts Target Price to $12 From $14
Avadel and Nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
